Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Earl Bakken

Alfred E. Mann

Daniel Grossman

Palmer Hermundslie

Medtronic plc

VirtuSense Technologies provides AI-powered solutions designed for integration throughout the healthcare continuum, focusing on prevention and improving care touchpoints.

VirtuSense Technologies

Vent Mechanical specializes in the provision of innovative engineering design and mechanical services installations. The company works across commercial, industrial, healthcare, and multi-residential sectors.

Vent Mechanical

山东前沿医疗器械股份有限公司 manufactures medical ozone therapy devices and other medical equipment, self-described as a high-tech enterprise.

Metric
Company Name	Medtronic plc	VirtuSense Technologies	Vent Mechanical	山东前沿医疗器械股份有限公司
Symbol	MDT
MSH ID	COM:MEDTRONIC	AI:VIRTUSENSE	AU:COM:VENTMECHANICAL	CN:COM:ZAMT
Market	STOCKS	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare	Healthcare & Health Services	Commercial & Professional Services	Healthcare & Health Services
Industry	Medical - Devices	Health Technology	Mechanical Services	Medical Devices
Country	IE	US	AU	CN
Stage
Employee Count	95K
Website	medtronic.com	virtusense.ai	ventmechanical.com.au	zamt.com.cn
LinkedIn			vent-mechanical-services
Founders

Metric
Market Cap	98.81B
Enterprise Value
Monthly Web Traffic	2.66M	3.12K	1.22K
Web Traffic Growth	0.29	2.79	1.28
Valuation
Raised Capital

Metric
Revenue	32.36B
Revenue (LTM)
Revenue (NTM)
Gross Profit	19.45B
EBITDA	8.38B
Operating Income	5.73B
Net Income	3.68B
EPS	2.77
Diluted EPS	2.76
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.66
Operating Profit Margin	0.18
EBITDA Margin	0.26
Net Profit Margin	0.13
Return on Equity	0.08
Return on Assets	0.05
Return on Capital Employed	0.07

COM:MEDTRONIC

Medtronic plc

Last Close

84.74

22/11 21:00

Market Cap

98.81B

Beta: -

Volume Today

5.40M

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	28.22
P/B Ratio	2.25
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	3.63
EV Multiple	12.19

Metric
Days Sales Outstanding	67.78
Days Payables Outstanding	71.76
Days Inventory Outstanding	187.43
Operating Cycle	254.83
Cash Conversion Cycle	189.62
Asset Turnover	0.36

Metric
Operating Cash Flow	6.79B
Free Cash Flow	5.20B
Cash Flow to Debt	0.27
Operating Cash Flow/Sales	0.21
Free Cash Flow Yield	0.03

Metric
Cash & Equivalents	1.28B
Accounts Receivable	-391M
Inventory	5.22B
Goodwill	40.99B
Debt to Capitalization	0.37
Debt to Assets	0.28
Current Ratio	2.29
Quick Ratio	1.61

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	0.01
R&D to Revenue	0.08
SG&A to Revenue